Effects of n-3 polyunsaturated fatty acid on upper limit of vulnerability shocks

International Journal of Cardiology
N ChattipakornSiriporn C Chattipakorn

Abstract

Ventricular fibrillation (VF) can be induced when a strong shock is delivered during the vulnerable period of a cardiac cycle. VF, however, cannot be induced if the shock strength is increased to the "upper limit of vulnerability" (ULV) level. Docosahexaenoic acid (DHA) has been shown to prevent the occurrence of VF after coronary occlusion. However, its effects on the ULV have not been verified. We tested the hypothesis that ULV shock strength is decreased after DHA administration. In 10 pigs, 10 S1s (square, 5-ms) were delivered from the RV apex electrode at 300 ms cycle length. Shocks (S2, biphasic) were delivered from the RV-SVC electrodes after the last S1. The ULV was determined using an up/down protocol. In group 1 (n = 5), after the control ULV was determined at the beginning of the study, a solution containing 1.0 gm of DHA was infused intravenously within 90 min. The ULV (DHA-ULV) was determined again after the end of infusion. In group 2 (n = 5), the vehicle for DHA was infused instead of DHA to confirm that the vehicle did not have an effect on the ULV. DHA-ULV (412 +/- 58 V, 12 +/- 3 J) was significantly decreased (P < 0.04) compared to the control ULV (478 +/- 32 V, 16 +/- 3 J). The ULV before (483 +/- 28 V, 16 +/...Continue Reading

References

May 9, 1985·The New England Journal of Medicine·D KromhoutC de Lezenne Coulander
Apr 25, 1995·Proceedings of the National Academy of Sciences of the United States of America·J X KangA Leaf
May 10, 1994·Proceedings of the National Academy of Sciences of the United States of America·G E BillmanA Leaf
Apr 16, 1996·Proceedings of the National Academy of Sciences of the United States of America·J X Kang, A Leaf
Apr 10, 1997·The New England Journal of Medicine·M L DaviglusR B Shekelle
Mar 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·J X KangA Leaf
Jul 27, 1999·Lipids·A LeafG E Billman
Jun 1, 2000·Circulation·N ChattipakornR E Ideker
Mar 14, 2002·The Journal of Membrane Biology·A Leaf, Y F Xiao
Jun 5, 2003·Pharmacology & Therapeutics·Alexander LeafGeorge E Billman
Sep 27, 2003·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Carl J WiggersMargaret Paine

❮ Previous
Next ❯

Citations

Dec 15, 2010·Future Cardiology·Wilbert S Aronow
Jun 18, 2010·Canadian Journal of Physiology and Pharmacology·Natnicha KanlopNipon Chattipakorn
Dec 26, 2006·International Journal of Cardiology·Nipon ChattipakornSiriporn Chattipakorn
Nov 18, 2009·American Journal of Therapeutics·Wilbert S Aronow

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.